Omeros Corporation
Omeros develops protein and small-molecule therapeutics targeting complement-mediated diseases, cancers, and neuropsychiatric disorders.
DEF 14AAug 21Latest SEC filing, period to Sep 30
Aug 13Latest story
Sign inSign inOmeros develops protein and small-molecule therapeutics targeting complement-mediated diseases, cancers, and neuropsychiatric disorders.